How I use GLP-1 receptor agonists to manage patients with type 2 diabetes, and why they warrant broad use across multiple patient populations.
An early experience with my mom’s type 2 diabetes taught me the importance of ensuring patients know what to expect when taking a new medication.
On-demand Webinar focusing on current best practices in leveraging GLP-1 RA therapy in T2D management.
For questions about content or obtaining CME credit, please contact the Endocrine Society at www.education.endocrine.org/contact.
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.